Table 3

Obtaining PreP and disclosure of PreP use to medical professionals

Country of residenceOn PrEPWhere was PrEP obtained? n (%)Is your sexual health physician/doctor aware? n (%)
PhysicianResearch studyInternetFriendTaken as PEPOtherYesNo
France*281175 (62.3)32 (11.4)15 (5.3)21 (7.5)20 (7.1)24 (8.5)170 (67.5)82 (32.5)
Russia19530 (15.4)8 (4.1)30 (15.4)23 (11.8)4 (2.1)4 (2.1)38 (49.4)39 (50.6)
UK*†1468 (5.5)18 (12.3)112 (76.7)6 (4.1)3 (2.1)7 (4.8)110 (78.0)31 (22.0)
Italy507 (14.0)9 (18.0)9 (18.0)2 (4.0)2 (4.0)1 (2.0)18 (69.2)8 (30.8)
Turkey9913 (13.1)6 (6.1)16 (16.2)14 (14.1)7 (7.1)5 (5.1)28 (58.3)20 (41.7)
Ukraine†6210 (16.1)4 (6.5)11 (17.7)8 (12.9)2 (3.2)0 (0)14 (66.7)7 (33.3)
Germany‡305 (16.7)2 (6.7)13 (43.3)4 (13.3)1 (3.3)3 (10.0)13 (65.0)7 (35.0)
Belgium*199 (47.4)4 (21.1)1 (5.3)1 (5.3)0 (0)3 (15.8)13 (86.7)2 (13.3)
Belarus173 (17.6)1 (5.9)4 (23.5)3 (17.6)1 (5.9)1 (5.9)5 (50.0)5 (50.0)
Spain131 (7.7)2 (15.4)2 (15.4)2 (15.4)0 (0)1 (7.7)5 (83.3)1 (16.7)
The Netherlands‡214 (19.0)7 (33.3)5 (23.8)1 (4.8)0 (0)2 (9.5)13 (72.2)5 (27.8)
Denmark143 (21.4)5 (35.7)1 (7.1)3 (21.4)0 (0)1 (7.1)12 (100)0 (0)
Switzerland85 (62.5)0 (0)5 (62.5)0 (0)0 (0)0 (0)4 (50.0)4 (50.0)
Portugal*61 (16.7)1 (16.7)2 (33.3)2 (33.3)1 (16.7)0 (0)4 (100)0 (0)
Sweden182 (11.1)0 (0)13 (72.2)1 (5.6)0 (0)1 (5.6)5 (29.4)12 (70.6)
Other9225 (27.2)9 (9.8)27 (29.3)17 (18.5)3 (3.3)7 (7.6)34 (59.6)23 (40.4)
Total1071301(28.1)108(10.1)266(24.8)108(10.1)44(4.1)60(5.6)486(66.4)246(33.6)
  • Note in the case of UK, PrEP is available in the national health system in Scotland, only via demonstrations or clinical trials in England and Wales, and not available in Northern Ireland.

  • *PrEP available as part of the national health system at the time of survey.

  • †PrEP available to a limited extent through demonstration projects or clinical trials.

  • ‡PrEP available at state-subsidised cost at the time of survey.

  • PrEP, pre-exposure prophylaxis.